Skip to main content
OpenTrials
Completed

NCT Number: NCT00957658

Accolade® TMZF® Hip Stem Outcomes Study

The purpose of this study is to evaluate clinical and radiographic outcome data in patients implanted with the Accolade® TMZF® femoral stem.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Newport Orthopaedic Institute, Newport Beach, California, United States

Loading trial locations.

About this study

A prospective, post-market, multi-centered clinical evaluation of the Accolade® TMZF® hip stem device. All patients enrolled will receive the study device. All study patients will undergo a preoperative central Dual energy X-ray absorptiometry (DXA) scan to determine bone mineral density (BMD) values.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient is a candidate for a primary total hip replacement.
  • Patient has primary diagnosis of osteoarthritis (OA).
  • Male and non-pregnant female patients ages 18 to 90.
  • Patient has signed an Institutional Review Board (IRB) approved, study specific Informed Patient Consent Form.
  • Patient willing and able to comply with postoperative scheduled clinical and radiographic evaluations and rehabilitation.
  • Patient capable of undergoing a pre-op central DXA (dual-energy x-ray absorptiometry) scan for a bone mineral density (BMD) reading.

Exclusion criteria

  • Patient has an active infection within the affected hip joint.
  • Patient requires a revision surgery of a previously implanted total hip arthroplasty or hip fusion to the affected joint.
  • Patient who is morbidly obese, Body Mass Index (BMI) > 40.
  • Patient has a neuromuscular or neurosensory deficiency, which limits ability to evaluate the safety and efficacy of the device.
  • Patient has the following diagnosed systemic diseases: Paget's disease, renal osteodystrophy, lupus erythematosus, rheumatoid arthritis, metabolic bone disease and sickle cell anemia.
  • Patient is immunologically suppressed or receiving chronic steroids more than 30 days. Patients receiving oral or IV steroids within one month of surgery.
  • Patient is a prisoner.

Treatment and study plan

Accolade® TMZF® Hip Stem

Device

Accolade® TMZF® Hip Stem

Primary outcomes

  1. Combined Percentage (%) Cases Without Aseptic Loosening, Intraoperative Femoral Fracture or Thigh Pain

    Time frame: 2 years

Secondary outcomes

  1. Percentage (%) of Hip Stems With Aseptic Loosening

    Time frame: 5 years

    Aseptic loosening is defined as a continuous radiolucency that surrounds the entire femoral stem porous coating-bone interface and that measures greater than 2 mm in thickness, and 5 mm or more of stem subsidence. Continuous radiolucency must be present in Zones 1, 2, 6 and 7 of the AP radiographic view and/or present in Zones 8, 9, 13 and 14 of the M/L radiographic view.

  2. Revision/Removal Rates

    Time frame: 2 and 5 years

    The percentage (%) of hips with revision or removal of any total hip replacement component (acetabular cup, femoral stem or femoral head) is reported at the 2 and 5 year postoperative intervals.

  3. Change in Harris Hip Score (HHS)

    Time frame: Preoperative, 2 and 5 years

    The change in HHS is reported by comparing the mean preoperative, 2 and 5 year postoperative scores. Scores can range from 0 to 100 with 0 being the worst and 100 being the best score. A score of 80-100 is considered good-excellent and a score of less than or equal to 79 is considered fair-poor. 90-100 = excellent, 80-89 = good, 70-79 = fair, 0-69 = poor.

  4. Change in SF-12 Score

    Time frame: Preoperative, 2 and 5 years

    The change in SF-12 is reported by comparing the mean preoperative, 2 and 5 year postoperative scores.The SF-12 Health Survey is a 12-item patient completed questionnaire to measure general health and well-being. It includes a physical and mental status component score; each ranging from 0-100. Low values represent a poor health state and high values represent a good health state.

  5. Change in Lower Extremity Activity Scale (LEAS) Score

    Time frame: Preoperative, 2 and 5 years

    The change in LEAS is reported by comparing the mean preoperative, 2 and 5 year postoperative scores.The LEAS is completed by the participant to assess activity level. Activity levels were ordered in terms of intensity from 1 to 18, with 18 indicating the highest activity level. The mean preoperative, 2 and 5 year scores are reported to assess improvement.

  6. PEQ (Patient Expectation Questionnaire) Overall Satisfaction

    Time frame: 6 months, 1 year and 2 years

    The PEQ is a study sponsor generated outcomes form. It is a one page questionnaire completed by the participant to assess lifestyle recovery post-surgery. Preoperatively, participants are asked to identify 3 of 12 different expectations that they most want to achieve after hip surgery. At 6 months,1 year and 2 years post-surgery participants evaluated the 3 expectations they identified and assessed their overall satisfaction and percent achievement.

    EXPECTATIONS KEY:

    Participate in recreational activities (dancing,traveling,gardening)

    Exercise or participate in sports

    Independently perform household chores/daily routine

    Easily change position,sit to stand/stand to sit

    Remove need for cane crutch or walker

    Use stairs normally step by step

    Ability to sleep through night

    Maintain social activites,caring for someone,playing with children

    Use public transportation or drive

    Maintain psychological well-being

    Maintain sexual activity

    Maintain employment

  7. PEQ (Patient Evaluation Questionnaire) Percent Achievement

    Time frame: 6 months, 1 year, 2 years

    The PEQ is a study sponsor generated outcomes form. It is a one page questionnaire completed by the participant to assess lifestyle recovery post-surgery. Preoperatively, participants are asked to identify 3 of 12 different expectations that they most want to achieve after hip surgery. At 6 months,1 year and 2 years post-surgery participants evaluated the 3 expectations they identified and assessed their overall satisfaction and percent achievement.

    EXPECTATIONS KEY:

    Participate in recreational activities (dancing,traveling,gardening)

    Exercise or participate in sports

    Independently perform household chores/daily routine

    Easily change position,sit to stand/stand to sit

    Remove need for cane crutch or walker

    Use stairs normally step by step

    Ability to sleep through night

    Maintain social activites,caring for someone,playing with children

    Use public transportation or drive

    Maintain psychological well-being

    Maintain sexual activity

    Maintain employment

  8. Acetabular Insert Wear

    Time frame: 5 years

    The linear wear rate of the polyethylene acetabular insert is measured radiographically and reported at 5 years.

  9. Wrist DXA Scan Analysis

    Time frame: 5 years

    DXA is a bone densitometry scan that measures bone mineral density and assigns a T-score. This score shows the amount of bone a patient has compared with a young adult of the same gender with peak bone mass. A score above -1 is considered normal. A score between -1 and -2.5 is classified as osteopenia (low bone mass). A score below -2.5 is defined as osteoporosis.

Sponsors and collaborators

Lead sponsor

Stryker Orthopaedics

Industry

Registry information

Official study title

Accolade® TMZF® Study A Prospective, Post-market, Non-randomized, Multi-center Evaluation of the Accolade® TMZF® Hip Stem

Important dates

Study start
2006
Primary completion
2011
Study completion
2014
First posted
Aug 12, 2009
Registry last updated
Aug 14, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.